Shah, Nalini S.

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

Nauck, M., Frid, A., Hermansen, K., Shah, N. S., Tankova, T., Mitha, I. H., Zdravkovic, M., Düring, M., Matthews, D. R., & for the LEAD-2 Study Group (2009) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 1,129

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

McClung, M. R., O'Donoghue, M. L., Papapoulos, S. E., Bone, H., Langdahl, B., Saag, K. G., Reid, I. R., Kiel, D. P., Cavallari, I., Bonaca, M. P., et al. (2019) · The Lancet Diabetes & Endocrinology

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 169

Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus

Parekh, D., Sarathi, V., Shivane, V. K., Bandgar, T. R., Menon, P. S., & Shah, N. S. (2010) · Endocrine Practice

Vitamin D Research StudiesDiabetes Treatment and Management

Cited by 78

Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing’s syndrome?

Budyal, S., Jadhav, S. S., Kasaliwal, R., Patt, H., Khare, S., Shivane, V., Lila, A. R., Bandgar, T., & Shah, N. S. (2015) · Endocrine Connections

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 19